Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Bartolomaeus, Hendrik (1) Blüthgen, Nils (1) Chen, Wei Prof. Dr. (2) Dechend, Ralf Priv. Doz. (2) Fischer, Cornelius Dr. (1) Forbes, Martin Dr. (1) Forslund, Sofia Dr. (1) Fritsche, Raphaela Dr. (2) Geisberger, Sabrina Yasmin Dr. (2) Herse, Florian PD Dr. (1) Kempa, Stefan Dr. (14) Kirwan, Jennifer Dr. (1) Landthaler, Markus Prof. Dr. (1) Marko, Lajos Dr. (1) Müller, Dominik Prof. Dr. (1) Schmidt-Krüger, Vanessa Dr. (1) Wilck, Nicola Dr. med. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) (-) Mastrobuoni, Guido Dr. (5) 2011 (4) 2012 (2) 2013 (3) (-) 2014 (1) 2015 (2) (-) 2016 (1) 2017 (2) 2018 (2) 2019 (2) 2020 (3) (-) 2021 (3) 2022 (2) 2023 (2) 2024 (1) Biology of Malignant Lymphomas (5) Epigenetic Modifications in Neuroblastoma (2) Experimental Ultrahigh-Field MR (6) Genome Engineering & Disease Models (1) Immune Regulation and Cancer (3) Magnetic Resonance (6) Mathematical Modelling of Cellular Processes (1) Mechanism-based Cancer Therapies (1) (-) Proteomics and Metabolomics (5) RNA Biology and Posttranscriptional Regulation (1) Transgenics (1) 5 Results: Active Filter: Mastrobuoni, Guido Dr.Proteomics and Metabolomics201420162021 Sort: Result score Newest to oldest Oldest to newest May 22, 2014 / Mol Cell MOV10 is a 5' to 3' RNA helicase contributing to UPF1 mRNA target degradation by translocation along 3' UTRs L.H. Gregersen M. Schueler M. Munschauer G. Mastrobuoni W. Chen S. Kempa C. Dieterich M. Landthaler March 04, 2016 / J Proteome Res Proteomics quality control : a quality control software for MaxQuant results C. Bielow G. Mastrobuoni S. Kempa March 01, 2021 / Int J Cancer Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma B. Arlt C. Zasada K. Baum J. Wuenschel G. Mastrobuoni M. Lodrini K. Astrahantseff A. Winkler J.H. Schulte S. Finkler M. Forbes P. Hundsdoerfer D. Guergen J. Hoffmann J. Wolf A. Eggert S. Kempa H.E. Deubzer January 19, 2021 / Epigenetics Chromatin Rbm10 facilitates heterochromatin assembly via the Clr6 HDAC complex M. Weigt Q. Gao H. Ban H. He G. Mastrobuoni S. Kempa W. Chen F. Li June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer
May 22, 2014 / Mol Cell MOV10 is a 5' to 3' RNA helicase contributing to UPF1 mRNA target degradation by translocation along 3' UTRs L.H. Gregersen M. Schueler M. Munschauer G. Mastrobuoni W. Chen S. Kempa C. Dieterich M. Landthaler
March 04, 2016 / J Proteome Res Proteomics quality control : a quality control software for MaxQuant results C. Bielow G. Mastrobuoni S. Kempa
March 01, 2021 / Int J Cancer Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma B. Arlt C. Zasada K. Baum J. Wuenschel G. Mastrobuoni M. Lodrini K. Astrahantseff A. Winkler J.H. Schulte S. Finkler M. Forbes P. Hundsdoerfer D. Guergen J. Hoffmann J. Wolf A. Eggert S. Kempa H.E. Deubzer
January 19, 2021 / Epigenetics Chromatin Rbm10 facilitates heterochromatin assembly via the Clr6 HDAC complex M. Weigt Q. Gao H. Ban H. He G. Mastrobuoni S. Kempa W. Chen F. Li
June 30, 2021 / J Enzyme Inhib Med Chem Inhibiting PHGDH with NCT-503 reroutes glucose-derived carbons into the TCA cycle, independently of its on-target effect B. Arlt G. Mastrobuoni J. Wuenschel K. Astrahantseff A. Eggert S. Kempa H.E. Deubzer